₹75
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Hetriva 18 Transdermal Patch used to treat dementia (memory loss) associated with Alzheimer's disease (a brain disorder that slowly destroys memory and thinking) and Parkinson's disease (a movement disorder that causes tremors and stiffness).
Hetriva 18 Transdermal Patch contains Rivastigmine, which increases the levels of a brain chemical called acetylcholine by blocking the enzyme responsible for its breakdown. This helps nerve cells communicate more effectively, supporting clearer thinking and improved memory.
Hetriva 18 Transdermal Patch is only for topical use (skin). Apply the patch exactly as prescribed by your doctor. Hetriva 18 Transdermal Patch may cause common side effects, including skin irritation at the application site, nausea, vomiting, dizziness, drowsiness, shakiness (tremor), weakness, weight loss, and loss of appetite. Please consult your doctor if these side effects persist or worsen.
Inform your doctor if you are allergic to Hetriva 18 Transdermal Patch or any of its components. Let your doctor know beforehand if you have breathing problems (asthma or COPD), stomach ulcers or bleeding, seizures, urination problems, or heart, liver, or kidney disease. Consult your doctor before using Hetriva 18 Transdermal Patch if you are pregnant, planning to become pregnant, or breastfeeding. Hetriva 18 Transdermal Patch is not recommended for use in children below 18 years of age.
Hetriva 18 Transdermal Patch is used in the treatment of dementia (memory loss) related to Alzheimer's and Parkinson's disease. The detailed uses of Hetriva 18 Transdermal Patch are as follows:
Hetriva 18 Transdermal Patch offers the following medicinal benefits:
Unsafe
It is advised to avoid alcohol consumption while using Hetriva 18 Transdermal Patch. Alcohol intake, along with Hetriva 18 Transdermal Patch, may cause increased dizziness and drowsiness. Please consult your doctor for more information.
Caution
Hetriva 18 Transdermal Patch should be used during pregnancy only if the benefit outweighs the risk. Please consult your doctor before using Hetriva 18 Transdermal Patch if you are pregnant or planning to conceive.
Caution
It is not known if Hetriva 18 Transdermal Patch is excreted into breast milk. Please consult your doctor before using Hetriva 18 Transdermal Patch if you are breastfeeding.
Caution
Hetriva 18 Transdermal Patch may cause dizziness or drowsiness. Do not drive if you experience any symptoms that affect your ability to drive or operate machinery.
Caution
Please consult your doctor before using Hetriva 18 Transdermal Patch if you have liver problems.
Caution
Please consult your doctor before using Hetriva 18 Transdermal Patch if you have kidney impairment.
Caution
It is unknown whether Hetriva 18 Transdermal Patch is safe for use in patients under 18 years of age. Please consult a physician for further information.
Caution
Hetriva 18 Transdermal Patch should be used with caution in patients with cardiovascular disease. Please inform your doctor about any existing heart problems before using Hetriva 18 Transdermal Patch.
Caution
Hetriva 18 Transdermal Patch should be used with caution in elderly patients. Please consult your doctor before use.
Dietary recommendations:
Physical activity:
Mental well-being:

Have a query?
Drug-Drug Interactions: Hetriva 18 Transdermal Patch may interact with certain medicines, potentially increasing side effects or altering their effectiveness. Inform your doctor if you are taking any of the following:
Drug-Food Interactions: Do not consume alcohol while taking Hetriva 18 Transdermal Patch, as it may lead to increased dizziness and drowsiness.
Drug-Disease Interactions: Hetriva 18 Transdermal Patch should be avoided or used with caution in people with:
Login/Sign Up
Login/Sign Up
RXSparsha Pharma International Pvt Ltd
₹140.62
(₹140.62 per unit)
Hetriva 18 Transdermal Patch used to treat dementia (memory loss) associated with Alzheimer's disease (a brain disorder that slowly destroys memory and thinking) and Parkinson's disease (a movement disorder that causes tremors and stiffness).
Hetriva 18 Transdermal Patch contains Rivastigmine, which increases the levels of the brain chemical acetylcholine by blocking the enzyme that breaks it down. This helps nerve cells to communicate more easily, supporting clearer thinking and better memory.
Hetriva 18 Transdermal Patch should be used with caution in the medical history of liver or kidney diseases, breathing problems (asthma and COPD), stomach/intestinal problems (ulcers and bleeding), heart diseases (sick sinus syndrome and other conduction disorders), fainting, fits, urination problems, and enlarged prostate. Please let your doctor know if you have any other medical problems before starting Hetriva 18 Transdermal Patch.
The transdermal patch is to be evenly applied to the skin without hair. It is advised to put the transdermal patch on clean, dry, and healthy skin on the upper or lower back. You can also apply it to the upper arm or chest. The patch should not be applied to damaged or broken skin. Please do not apply a new patch if you are already using one, as it can lead to overdosing. Do not apply creams, oils, lotions, or powders to the application site. Sometimes, a patch may contain metal. Therefore, it is recommended to remove the patch before undergoing MRI.
After using the patch, fold it in half with the adhesive surfaces pressed together inwards, and discard it safely.
Disclaimer